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Colicine K,  isolated from Escherichia  coil  K  235,  has been shown  to be a 
lipocarbohydrate-protein complex that is serologic.ally  and chemically similar 
to the O antigen of this strain of bacteria (I-3). Colicine K  differs from other 
O  antigens in  that  it possesses antibiotic activity toward susceptible E. coIi 
(4). The antibiotic activity, which resides in the protein moiety of the com- 
plex is closely associated with the lipocarbohydrate but can be extracted with 
organic solvents, and thus does not appear to be covalently linked (5). Colicine 
K  was thought to be related to the tail antigen of T6 bacteriophage (4). Since 
the neutralization of T2, T4, and T6 bacteriophage by normal human serum 
was under investigation at that time (6), an attempt to demonstrate a phage- 
related structure in  colicine K  by neutralization of its antibiotic activity by 
normal human serum was made. Neutralization of antibiotic activity was not 
observed.  Instead,  its  antibiotic  activity toward  susceptible  E.  coli  was  en- 
hanced many fold (7). Subsequently, it was shown that no serological relation- 
ship  exists  between  collcine K  and  bacteriophage  T6  (2).  Enhancement  of 
antibiotic activity of colicine K  by serum had been observed earlier (8,  9,  2) 
but no attempt at purification of the factor responsible for the observed en- 
hancement had been reported. 
Our  earlier  investigations  on  the  nature  of  the  colicine-enhancing factor 
(CEF) in serum showed it to be present at highest concentrations in fraction 
IV-1 obtained by subjecting outdated human plasma to the ethanol fractiona- 
tion  method  of  Cohn  et  al.  (7).  However,  it  was  subsequently  found  that 
lysates  of red  blood  cells  were far more potent  in  enhancing  the  antibiotic 
activity of  colicine K  and  that  hemoglobin and  its  constituent  chains  were 
the active components (10). Since colicine K  is a good antigen, the interaction 
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of hemoglobin and its subunits with colicine K  was also studied by observing 
alteration  of  serological properties.  This  latter  nmnifestation of  the  colicine 
K-hemoglobin interaction,  i.e.  alteration  of  serological  properties,  was  also 
observed with  other  0  antigens lacking antibiotic activity. 
This communication describes studies in which the effects of environmental 
factors  on the  interaction of hemoglobin and its  chains with  colicine K  and 
0  antigens were investigated. Some of the experiments with serum and tissue 
fractions and their relationship to the hemoglobin system are also considered. 
Materials and Methods 
Colicine K  and 0 Antigens.--Colicine  K was the generous gift of Dr. W. F. Goebel of The 
Rockefeller  Institute. Escherlchia coli endotoxin (from strain 0111 :B4) and its antisera were 
given to us by Dr. J. Fine, Beth Israel Hospital, Boston. Shigdla flexneri  and Salmonella 
typhimurium  endotoxins and antisera were  given to us by Dr.  S. B. Formal, Walter Reed 
Army Institute of Research,  Washington, D.C. The lipopolysaccharides  of Serratia marcescens, 
Salmonella enteritidis and Salmonella typhosa were purchased from Difco Laboratories, Inc., 
Detroit. 
Hemoglobin and Its Ckains.--The twice crystallized human hemoglobin was obtained from 
Pentex Inc., Kankakee, Illinois; the alpha and beta chains of human hemoglobin, purchased 
from Gallard-Schlesinger  Chem. Mfg.  Co.,  Carle Place, New York, had been prepared by 
countercurrent distribution (11). Amino acid analysis of the alpha chain agreed with the pub- 
llshed values; analysis of the beta chain revealed the presence of 0.1S residue of isoleucine 
which may indicate contamination  by fetal hemoglobin or a non-berne protein (I 1). Since the 
chains were not easily soluble and tended to aggregate on prolonged standing in aqueous solu- 
tions, a stock solution (2 mg/ml) was made hy dissolving them in 2 ~ urea. 
Assay for Enha~ement o] Colicine K Actidty.--Prior to setting up the enhancement assay, 
it was necessary to determine the activity of the colicine K preparation using a modified zone 
inhibition  assay on nutrient agar plates seeded with E. coli B (12). Twofold serial dilutions of 
colicine K  were made in 0.005 ~  phosphate buffer,  pH 6.8, and 0.01 ml from each reaction 
mixture  was applied to the appropriate segment of the seeded plate. Under our conditions, the 
final dilution that gave a  zone of inhibition contained 0.1  ~g of colicine K  in the 0.01 ml 
applied to the plate (I0 #g colicine K/ml of dilution mixture). The amount required to give 
an end point can vary over a 2-fold range. The specific activity of the colicine K preparations 
was lower than that found by Dr. Goebel under his assay conditions, probably reflecting some 
differences  in the two assays; e.g., number of organisms applied to the plate and time of 
preincubating the plate prior to assay. 
For measurement of the enhancement activity, six or eight 2-fold serial dilutions of the 
factor to be tested were made in 0.005 ~ phosphate buffer (pH 6.8) in a total volume of 0.2 
ml. To each tube was then added 0.2 ml of a constant but suboptimal amount of colicine K. 
This concentration of coficine K  was usually one-fourth to one-sixth the amount previously 
found to be necessary to give a zone of inhibition. After incubation for 1 hour at 37°C, 0.01 
ml was taken from each tube and applied to the plate. The end point for the collcine-enhanc- 
ing factor is that concentration of sample giving a complete zone of inhibition  with the sub- 
optimal amount of colicine K. As a control, this suboptimal concentration of colicine K was 
incubated under the identical assay conditions and did not give a  zone of inhibition. The 
extent of enhancement of a given preparation of colicine can vary from 6- to 200-fold depend- 
ing on whether the zone inhibition  or viable cell assay is used. At least two factors responsible 
for this variation, the number of bacteria (8) and the growth phase of the bacteria, have been 
recognized. H.  VAN VUNAKIS~ A.  RUFI~ILLI~ AND L.  LEVINE  263 
Alteration of Serdogical Aaivity.mln general,  the effects of hemoglobin, alpha and beta 
chains,  sera, or tissue fractions on the serological activity of collcine K, E. cobi endotoxln, 
fetuin, and pneumococcus polysaccharides  were measured by incubating the antigen with the 
sample being tested in total volume of 3.0 ml  of phosphate  buffer.  After incubation,  an 
aliquot was removed and diluted into chilled buffer (0.01 M tris, pH 7.4, 0.140 M NaC1) and 
assayed for its C'-fixlng capacity using a  micro-C' fixation  assay (13). Variations of this 
general scheme will be presented in detail with the appropriate experiment. 
Colicinc K Antisera.--For production of rabbit antisera, 500/~g of colicine K in a volume 
of 1.0 ml was mixed with an equal volume of complete Frennd's adjuvant and injected into 
the toe pads and intramuscul~fly. The rabbits were bled three weeks after the initial injection 
and were boosted with 500 t~g of colicine K by the same procedure. After the second bleeding, 
the rabbits were given an additional  immunizing dose of 500 ~g. The antibodies formed against 
the colicine K complex are to a large degree oriented toward the lipocarbohydrate moiety (2). 
Chromatographic Teckniques.---The  chromatographic techniques  used will be referred to in 
the specific experiment. 
RESULTS 
Analyses of Sera, Plasma, Cokn Fractions, and Tissues for CEF.--The data 
presented  in  Table  I  show  that  CEF  was  present  in  the  sera of all species 
tested;  CEF was not affected by dialysis or by passage through a  column  of 
cation exchange  resin  (IRC-50)  in  the  sodium cycle; or by heating  at  90°C 
for 10 minutes. Asking, however, completely destroyed its activity. Individual 
human  sera varied somewhat in  their activity and pools of sera and plasma 
varied within  a  4-fold range. 
Cohn fractions I, II, III, IV-l, V,  and  super V,  which had  been prepared 
by Method  6  from  outdated  plasma at  the New  York  State Department  of 
TABLE I 
Assay of Sera and Plasma  for Abiliiy to Enhance the Antibiotic Ac#ivity of Cdicinc K 
Sample 
Human serum 
Individuals 1, 2, and 3 
Final dilution 
required for 
complete zone 
of mhibitlon 
l/i6o,  lmo, i 
and 1/640 
Sample 
Human plasma, outdated pool 
Beef serum (1) 
Rabbit serum (1) 
Pool of 6 specimens 
Individual 4 
Individual 4 dialyzed 
Individual 4 through cation 
exchange resin 
Individual 4 heated at 90°C 
for 10 rain.  at a  I:10  dilu- 
tion 
Individual 4 ashed 
1116O 
1/82o 
1/82o 
1/32o 
1/320 
>ill 
Cow serum (1) 
Hamster serum (I) 
Chicken serum (1) 
Guinea pig serum (1) 
Rat serum (I) 
Mouse serum (1) 
Final dilution 
required for 
complete zone 
of inhibition 
~/040 
1/16o 
1/160 
1/80 
1/82o 
1/16o 
1/40 
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Health, were assayed for CEF. Fraction IV-1 was the most potent fraction 
giving a complete zone of inhibition at 25/~g/ml.  This fraction contains some 
albumin and beta globulins but is particularly rich in alpha globulins.  CEF 
was stable  on exposure to pH 2-11 for several hours at 0°C and to digestion 
by trypsin and chymotrypsin at pH 7.0. However, if fraction IV-1 was treated 
at 90°C for 10 minutes prior to enzymatic digestion,  CEF activity was com- 
pletely destroyed by trypsin and chymotrypsin. Electrophoretic  analysis  of 
sera and fraction IV-1 showed that CEF migrated mainly as an alpha 2 globu- 
lin. Some purification of CEF from fraction IV-1 was possible with (NH4)~SO4 
and  ethanol  precipitation  and  chromatography on  DEAE  cellulose. CEF 
activity emerged in two peaks.  Rechromatography of the peaks  gave  addi- 
tional splitting of the peaks  (14). The most potent CEF fraction was active 
at a  concentration of  I0 to  15  #g/ral. 
Analysis of fraction IV-1 obtained from four different laboratories  showed 
variation in CEF activity of from 5- to 20-fold compared  to the New York 
State Department of Health preparations.  An attempt was  therefore  made 
to isolate CEF directly from sera using chromatography on DEAE under the 
conditions described by Sober et al. (15). The activity emerged as a peak coin- 
cident with the hemoglobin-haptoglobin  complex (15). 
Homogenates  of various  tissues  were also made and tested for CEF and 
for their ability to alter the serological activity of colicine K. Every tissue 
tested possessed some  activity but,  in general,  spleen,  heart,  kidney, liver, 
and muscle had the highest specific activity. Two procedures  were developed 
for the isolation of CEF from spleen and heart. One consisted of homogenizing 
the tissue, centrifuging  the insoluble material, adjusting the pH of the super- 
natant fluid to 2 and heating it at 100°C for 10 minutes. Upon cooling, the 
homogenate  was neutralized and clarified by centrifugation.  The supernatant 
fluid was  extracted with saturated phenol  and  CEF was  precipitated from 
the phenol layer by addition of acetone. It was redissolved in saline-phosphate 
buffer and the insoluble material was removed by centrifugation.  The super- 
nate contained the CEF. 
The  second  procedure  consisted  of suspending  the  tissue  homogenate in 
8 ~  urea at pH  2,  precipitating inactive protein with 2 per  cent TCA and 
then precipitating active protein with 5 per  cent TCA.  Chromatography on 
the cation exchange resins XE-64  and carboxymethyl cellulose (CMC)  using 
aqueous  solvents proved difficult since the preparations tended to aggregate. 
Chromatography in  urea  appeared  more  promising. 
CEF Activity  of Hemoglobin, Its Subunits,  and Myoglobin.--While  the above 
studies  were in progress, two hemolyzed bloods from duck and monkey were 
analyzed for CEF. Whereas  the highest titer of sera  or plasma was  1/640, 
these hemolyzed bloods were active at 1/60,000. In order to test the effect of 
the hemolytic products, fresh sheep blood was separated into its cellular and 
plasma  components  and  assayed for  CEF.  While  whole  blood  and  plasma ~. VAN VUNAKIS, A. RD~I-LLI, AND  L. LEVlN'E  265 
were active at a  1/200 dilution,  the lysed cells were active at 1/30,000  (10). 
Since  there are 11 gm of hemoglobin  in  100 ml of sheep blood, this dilution 
represents  3.7  ~g  of  hemoglobin  assuming  quantitative  recovery from  the 
lysed blood cells.  Twice crystallized sheep hemoglobin  was active at a  con- 
centration of 1.6 gg while similar hemoglobin preparations from various species 
were found to be active at the following  levels:  human  (1.6 #g), rabbit  (1.6 
#g), guinea pig (1.6 #g), sheep (1.6 #g), rat (6.4 #g), and pork (1.6 #g). Crystal- 
line  human hemoglobin was also chromatographed on CMC according  to the 
procedure described by Reichlin et al.  (17)  and  the effluent  pattern  of CEF 
activity was found to correspond to the major peak of optical density of 410 
mg  (hemoglobin  A0.  There  was  no  appreciable  loss  in  collcine  enhancing 
activity when  hemoglobin  was  treated  with  acetone-HC1  to  prepare  globin 
(18) nor when giobin was subjected to urea-HC1  to split it into chains  (19). 
A concentration of 1.6 #g of alpha and beta chain of hemoglobin  was sufficient 
to enhance the activity of colicine K. Hemin was tested and found to be in- 
active.  These  experiments  indicated  that  hemoglobin  and  its  protein  com- 
ponents were the active principles  in lysates. 
Since  myoglobin  resembles  hemoglobin  in  its  tertiary  structure  and  has 
some similar  areas of amino acid sequences (20), it was assayed for its ability 
to enhance the activity of colicine K. The twice crystallized horse myoglobin 
used in these studies had been shown by immunological  and chromatographic 
techniques  to  be  contaminated  with  approximately  3  per  cent  hemoglobin 
(17). It was therefore dialyzed in 0.01 M phosphate buffer, pH 6.4, and chro- 
matographed  on a  CMC column equilibrated with the same buffer utilizing 
a pH gradient of 0.01 phosphate buffer, pH 8.3 for elution of the protein (17). 
Myoglobin As, accounting for 90 per cent of the material emerged at an effluent 
pH  of  6.7.  The  colicine-enhancing  activity  coincided  with  the  myoglobin 
elution pattern.  The chromatographically purified  myoglobin gave a complete 
zone of inhibition  at a  concentration of 6 #g, ml. 
Other  purified  proteins  had  been  tested  for  colicine~enhancing  activity 
(10).  Egg white lysozyme had activity, but was only 5 per cent as effective 
as hemoglobin and its subunits. Lysozyme, however, can enhance the activity 
of other antibiotics probably by causing  changes  in the cell wall  (21).  Ribo- 
nuclease,  another  small  basic protein,  showed no activity at  200 #g/ml.  In- 
cubation of colicine  K  with levels  of poly-L-lysine  and poly-L-giutamic  acid 
of up to 50 #g/ml  did not give enhancement  of activity. 
The effect of time and temperature on the ability of hemoglobin  to enhance 
the activity of colicine K  was tested. These results axe only semiquantitative 
for the following reasons: (a) In our hands, the zone inhibition assay can vary 
by a  factor of 2;  (b) Since the plates have to be incubated to allow bacterial 
growth  to  take  place,  the  reaction  between colicine  K  and  the factor may 
continue after the reaction mixture is applied to the seeded plate for assay. 
Nevertheless,  some general  conclusions  could be made from these studies. 266  ALTERATION  OF COLICINE K 
The reaction was both temperature- and time-dependent. It did not proceed 
appreciably at  0°C  and  required progressively less  hemoglobin to  reach  an 
end point when the reaction mixtures were incubated at 25  ° and 37°C. High 
concentrations of hemoglobin and alpha chain did not affect CEF activity as 
measured by the zone inhibition assay. 
Effect of Hemoglobin and Its Subunits  on the Serological Activity of Colicine 
K  and 0  Antigen3.--Colicine  K  or E. coli endotoxin, assayed with homologous 
antisera by C' fixation gave a  characteristic antigen-antibody response curve. 
When colicine K  or E. coli endotoxin was incubated with serum,  plasma,  or 
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FIG. 1.  The effect of various concentrations of hemoglobin on the serological properties of 
colicine K. Colicine K  (1.65 ttg/ml) was incubated with various concentrations of hemoglobin 
at 37°C for 30 minutes. Samples  were diluted and assayed for C' fixation  using anticolicine  Ra, 
No. 456-B2, at a 1/600 dilution. 
tissue  homogenates,  alterations  in  their  serological response  were  observed. 
Lysed red cells were again 2 to 3 orders of magnitude more effective at altering 
these  serological activities  than  serum,  plasma,  or  washed  whole  red  blood 
cells (10). Twice crystallized human hemoglobin and the alpha chain decreased 
the fixation of C' 50 per cent at levels of 1.6/zg, while 4.1  gg of beta chain 
was required for similar alterations.  Since antisera to colicine K  are directed 
mainly toward the lipocarbohydrate component (2), changes in the serological 
response probably reflect to  a  large  extent alterations  in  the  antigenic  de- 
terminants  of the lipocarbohydrate moiety. The quantitative immunological 
technique was used to study the effect of temperature, divalent cations, salt 
concentrations, time, and protein (hemoglobin and its subunits) concentration 
on the serological activity of colicine K  and E. coli endotoxin. 
The data shown in Fig. 1 represent the serological responses after incubation 
of a  constant  quantity of colicine K  with  various  amounts  of  hemoglobin. H.  VAN  VUNAKIS,  A.  RDT]~ILLI,  AND  L.  LEVINE  267 
When measured as the per cent decrease in C ~  fixation, preincubation of colicine 
K  with  1 #g hemoglobin decreased serological activity  approximately  60 per 
cent, while incubation with 4 #g hemoglobin resulted in a decrease in C' fixa- 
tion of 75  per cent.  Incubation  with  16 #g hemoglobin caused a  reversal  of 
this  trend;  the  maximum  C' fixation was now within  25  per cent  of  the  C' 
fixed by  the  colicine control incubated  with buffer.  Fig.  2,  in which the per 
cent  decrease  in  C'  fixation  is  plotted  against  the  amounts  of  hemoglobin 
reacting  with  a  constant  quantity  of  colicine  K,  summarizes  the  results  of 
several  experiments.  Such  a  response  curve  resembles  the  antigen-antibody 
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FIG. 2. The effect of various concentrations of hemoglobin on the serological  properties of 
colicine K. Colicine K (1.65/sg/ml) was incubated with various amounts of hemoglobin  under 
the conditions described in Fig. 1 and assayed with anticolicine. 
precipitin  or  C' fixation  curve  in  that  the  interaction  observed is  inhibited 
by an  excess of one of the  reactants. 
Fig.  3  shows  the  effect of NaC1  concentration  on  the  reaction.  At 0.75 
NaC1,  the  colicine  K-hemoglobin interaction  was  completely inhibited.  The 
interaction  of colicine K  and hemoglobin was rapid,  the reaction being com- 
plete in  10 minutes at 37°C  (Fig. 4). 
Fig.  5  shows  the  results  obtained  when  E.  coli  endotoxin  and  the  alpha 
chain  of hemoglobin were  incubated  in  the  presence of varying amounts  of 
Ca++. It can be seen that in the presence of 3  X  10  -* M Ca  ++ the interaction 
was completely inhibited.  Table II shows the effect of other divalent cations 
on the interaction of colicine K  with alpha chain.  Of the cations tested, Zn  ++ 
and  Cd  ++  were  the  most potent  inhibitors  followed by Ba  ++,  Mn  ++,  Co  ++, 
Ca  ++,  Mg  ++,  and Sn  +~.  The effects of Ca  ++,  Mg  ++, and Mn  ++ on the inter- 268  ALTERATION  O]F COLICINE K 
8O 
K,I 
Z 
.J 
o  60 
LL 
0 
Z 
_o 
X 
I11 
w 
w 
a 
!  I 
0  0.25  0.5  0.75  1.0 
(MOLARITY  NoCI  ADDED) 
FIG. 3.  The effect of ionic strength on the serological alteration of colicine K  (1.6/~g/'ml) 
incubated with alpha chain (3.0 ~g/ml) in 0.005 ~  phosphate buffer, pH 6.8, for 30 minutes 
at 37°C. The molarity of NaC1 was varied and all reaction mixtures were in a final volume o[ 
3.0 ml. 
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FIG. 4.  The per cent decrease in C' fixation when colicine K  (1.65 #g) and hemoglobin (2.0 
gg) were incubated for different intervals, and then diluted and assayed with anticolicine. H. VAN VUNAKIS,  A. I~YF]~ILLI, AND  L. LEVINE  269 
action of E. coli endotoxin and alpha  chain were of the same order as that 
found with the colicine K  system. 
The results obtained when a  constant amount of colicine K  was incubated 
at different temperatures with various concentrations of alpha chain are sum- 
marized in Table HI. At weight ratios of alpha chain to colicine K  below 2, 
the extent of reaction after incubation for 30 minutes was relatively slow at 
20°C, reached a  maximum at 60 to 80°C and decreased slightly at 80°C and 
100°C.  At  certain temperatures,  e.g. 60°C  and  at  alpha  chain  to colicine K 
ratios above 5,  the reaction was markedly inhibited. 
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FIo. 5.  The effect of varying concentrations of calcium on the C' fixation of E. coli endo- 
toxin with anti-E, coli endotoxin. Endotoxin (5.6 ug/ml) was incubated with 10 ttg of hemo- 
globin in buffer containing various amounts of Ca  ++. 
Properties  of  the  Colicine K  Hemoglobin  or  Alpha  Chain  Complex.--Gel 
filtration on sephadex g  100  was used to determine whether colieine K  under- 
went  changes  in  molecular  weight  during  its  interaction  with  hemoglobin 
components. The eluted fractions were assayed by zone inhibition to determine 
the position in the chromatogram of the antibiotic activity and by immuno- 
logical techniques to determine the location of the lipocaxbohydrate moiety. 
In  experiment  1  (Table  IV)  colicine K  was  passed  through  a  column of 
sephadex 100 and the fractions which emerged were assayed for their ability 
to prevent growth of E. coli B. Antibiotic activity was present in tubes  15 
through  18.  If aliquots were taken from these tubes and preincubated with 
CEF (in this experiment rabbit serum was used as a  source of CEF) and re- 
assayed by zone inhibition, activity was found in tubes  14 to 20.  Therefore, 
the colicine K  activity emerged in a  discrete peak and further activation did 
not reveal any additional activity in other parts of the ehromatogram. When 270  ALTERATION OF  COLICINE K 
colicine K  was preincubated with rabbit sera  (Experiment 2, Table IV)  and 
then passed through sephadex 100, the activity was found in tubes 15  to 39. 
The  active moiety was  therefore  significantly retarded,  suggesting that  the 
activity resided in a  smaller molecule(s). 
TABLE II 
Effect of Divalent Cations on Alteration of Serological Activity of Colicine K  and 
E. coli Endotoxin by {x-Chain 
Cation 
Calcium 
Magnesium 
Strontium 
Barium 
Manganese 
Cobalt 
Zinc 
Cadmium 
Molarity 
3.3 X  10-  3 
3.3 X  10  -4 
3.3X 10  -~ 
5 X  10-  3 
5 X  10  -4 
5XiO ~ 
3.3 X  10  -3 
3.3 X  10  -4 
3.3 X  10-  5 
3.3X 10-6 
3.3 X  10  -4 
3.3 X  10  -5 
5X 10-6 
5 X  10  -4 
5 X  10  -5 
3.3 x  to-6 
3.3 x  10  -4 
3.3x  10  ~ 
3.3 X  10  -4 
3.3 X  10  -5 
3.3 X  10-  6 
3.3 X  10  -4 
3.3X 10  ~ 
3.3 X  10  -6 
Colicine  K 
per cent 
78 
39 
19 
68 
31 
22 
79 
36 
14 
97 
95 
73 
i00 
70 
25 
82 
58 
46 
i00 
100 
81 
Inhibition 
83 
89 
73 
E. coli endotoxin 
psr c$~ 
100 
50 
27 
74 
53 
17 
100 
76 
18 
These experiments were repeated using alpha chain to enhance the activity 
of  colicine K  rather  than  sera.  Essentially the  same  results  were  obtained 
(Experiments 3  and 4,  Table IV). The antibiotic activity of colicine K  was 
enhanced at least 6-fold in these  experiments. Within the limitations of  the H.  VAN  VUNAKIS,  A.  RU-I?FILLI, AND  L.  LEVINE  271 
TABLE HI 
Effect  of Temperature  on the Alteration  of Serological Activity of Colicins K  by the or-Chain 
of Human Hemoglobin 
a-Chain 
Pg 
1 
2 
4 
8 
16 
32 
Decrease in max. C' fixation 
20°C 
~er cent 
8 
6 
8 
20 
64 
40°C 
per cent 
46 
58 
68 
77 
81 
60°C 
~er ~ent 
50 
63 
83 
75 
81 
79 
80°C 
per cent 
45 
74 
74 
62 
46 
0 
100°C 
per cent 
68 
6! 
61 
55 
0 
0 
1.65 #g colicine K/ml is incubated with varying amounts of a-chain under standard  as- 
say conditions. 
TABLE IV 
The Elution Patterns  oJ Antibiotic  Activity of Colicine K  and Colicine K  Preincubated  with 
Sera or Alpha Chain after Passage through a Sephadex G 100 Column 
Exp. No.  Conditions 
500 #g col/cine K preincubated in 3.0 ml phos- 
phate buffer, 37°C,  60 min. 
500 #g colicine preincubated with 0.2 ml rabbit 
sets in a total volume of 3.0 ml buffer,  37°C, 
60 min. 
600/~g colicine K preincubated in 3.0 ml buffer, 
37°C,  60 rain. 
600  #g colicine K  preincubated  with  500  #g 
a-chain in 3.0 ml buffer,  37°C, 60 rain. 
Tubes containing activity 
A* 
15-18 
15-39 
15-18 
15-38 
B~ 
14-20 
15-21 
The sephadex column was 4 cm in diameter x 40 cm long, the effluent buffer was 0.005 
M PO4 (pH 6.8) and the fractions were collected in 3 ml aliquots. 
* Aliquots (0,2 ml) were removed from each of the effluent tubes into 0.2 ml of phosphate 
buffer and then assayed directly by the zone inhibition assay. 
:~ Aliquots (0.2  ml) were removed from each tube into 0.2  ml of phosphate buffer con- 
taining at  1/100 dilution of rabbit  sera and  preincubated  for 60  minutes at 37°C prior to 
assay. 
zone  inhibition  assay,  approximately  50  per  cent  of  the  activity  could  be 
accounted  for in  the  broad  peak. 
In  comparable  experiments,  colicine  K  was  passed  through  a  sephadex 
100  column and  assayed  immunologically. This activity  was  found  to  emerge 272  ALTERATION  OF  COLICINE  K 
between tubes 25 to 35  (Fig. 6).  Aliquots from the peak portion of the curve 
all showed the same C' fixation. Using the extent of the lateral shift, the amount 
of material that emerged in each tube was quantitated. The C ~ fixation curves 
obtained from tubes  23,  30,  and 36 are shown in Fig.  6. 
Preincubation of colicine  K  with  alpha  chain,  followed by passage of the 
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FIG. 6. Top left; the chromatogram resulting from the passage of 100 ~g of colicine K 
through a sephadex 100 colunm (1.8 x 100 cm) equilibrated with 0.005 •  phosphate buffer at 
pH 6.8. Top right; the C  ~  fixation curves obtained when aliquots of the individual tubes were 
assayed. 
Bottom left; the chromatogram resulting from the passage of the preincubated reaction 
mixture containing 100 #g of colicine K and 200 #g of alpha ctmin through the same column. 
Bottom right; the C' fixation curve obtained when aliquots of individual tubes were assayed. 
reaction mixture  through this  same  sephadex  column revealed  that  the  im- 
munological activity emerged  in  essentially  the  same  place.  All  tubes  con- 
taining antigen showed a  decreased maximum C I fixation.  C  r fixation curves 
obtained with known amounts of alpha chain were used as calibration curves 
to quanfitate the altered colicine  K  that emerged from the column, The first 
tube in the eluting peak, No. 23,  showed the greatest decrease in  C' fixation 
suggesting that the maximum interaction of alpha chains with colicine  K  had 
occurred in the  early tubes.  Indeed, because of such interaction,  even larger 
molecular weight products may have been formed. The 2 to  1 ratio of alpha l:I.  VAN  VUNAKIS~  A.  RUF~ILLI~  AND  L.  LEVINE  273 
chains  to colicine K used in the experiment as well as the incubation tempera- 
ture  (37°C)  preclude  the possibility that  serological  activity in  other  tubes 
was being overlooked because of the reversal of inhibition (e.g. alpha chain at 
a  concentration  of 32 ~g at  80°C,  Table III).  In  addition,  tubes along  the 
chromatogram  were  assayed with  increased  concentrations  of antibody but 
none outside of the peak fractions (23 to 35) possessed any C r fixing capacity. 
Nor did they contain any fragments capable of inhibiting the intact antigen- 
antibody  C'  fixation.  Similar  gel  filtration  properties  were  observed  with 
E.  coli  endotoxin  before and  after  incubation  with  hemoglobin. 
Since  the  immunological  activity  was  not  appreciably  displaced  in  the 
elution  pattern  of  the  chromatogram,  the  lipocarbohydrate  moiety did  not 
appear to have undergone fragmentation to units of smaller molecular weight. 
The significant  retardation of the moiety having the antibiotic activity, how- 
ever, suggested that  it was now smaller in molecular weight.  The broadness 
of the eluting peak may represent some heterogeneity in the molecular weight 
and/or in the charge of the active fragment. In any case, it appears that the 
lipocarbohydrate moiety and the alpha chains have interacted, and in so doing 
have  changed  the  characteristics  of the antibiotic  moiety so that  it is now 
retarded during gel filtration.  Prior to carrying out the physical and chemical 
studies necessary to determine the properties of the antigenically and biologi- 
cally active fragments,  attempts are being made to determine why the anti- 
biotic activity emerges  in such a  broad peak. 
Interaction  of Alpka Cltains wilk Otker Immune Systems.--The  progressive 
loss of  C r fixation obtained by incubating  colicine  K  and  E.  coli  endotoxin 
with increasing  amounts of alpha chain was also found with the S. typkimurium 
and Sh. flexneri endotoxin immune systems. Although anfisera to endotoxins 
isolated from S.  typkosa,  S. enteritidis,  and S. marcescens  were not available, 
their interaction  with alpha chain  was demonstrated by their ability to com- 
pete with colicine K  for the alpha chain.  An experiment demonstrating  this 
competition is summarized in  Fig.  7.  Various  amounts of heterologous lipo- 
polysaccharide  were  incubated  with  a  constant  amount  of colicine  K  and 
alpha chain.  S.  marcescens,  S.  typhosa,  and  S.  enteritidis  lipopolysaccharides 
inhibited  the  serological  alteration  of  colicine  K  caused  by  alpha  chain. 
Although  all  the  endotoxins  tested  showed  this  competitive capacity, the 
amount  required  to  inhibit  the alteration  of  C p fixation  50 per cent varied 
with different preparations. 
Incubation with alpha chain or hemoglobin did not alter the C r fixation  of 
three Pneumococcus  polysaceharide immune systems. Nor did alpha chain alter 
the T4 DNA immune system in which the glucosylated hydroxymethylcytosine 
is part of the antigenic determinant (22). In agreement with these findings, the 
pneumococcus polysaccharides and  T4 DNA did not inhibit  the reaction of 
alpha chains  with colicine K. 274  ALTERATION 0~'  COLICINE K 
A small but reproducible alteration was seen with the fetuin immune system 
However, the interaction of alpha chain with this glycoprotein resulted in an 
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FzG. 7.  Tnhibition of the colicine K-alpha chain interaction by S. enteritidis,  S. mercescens 
and S. typhosa endotoxins. A constant amount of colicine K  (1.6 gg/ml) and varying amounts 
of the heterologous lipopolysaccharides were incubated with a constant amount of alpha chain 
(3.2 gg/ml) and assayed with anticolic.£ue K. 
I00 
80 
Z 
0 
F-  60 
x 
IJ.. 
"o  40 
20 
5/J,g  Hb 
I 
0.1 
t.L9  FETUIN 
Hb 
I.O  LO 
SIALIC ACID-FREE  FETUIN 
IN 
I 
0.1 
~g  FETUIN  EQUIVALENTS 
FIG. 8.  The effect of hemoglobin on the serological  activity of fetuin. Left, 5 ag of fetuin 
were incubated at 37°C for 30 minutes in phosphate buffer 0.005 ~ at pH 6.8 (bottom curve) 
and with 5 ~g of hemoglobin (top curve). Right, from reference 23. 
increase in C' fixation (Fig. 8). A similar increase in C' fixation as a  result of 
removing sialic acid with neuraminidase had been noted in an earlier study of 
the fetuin amino system (23). Since antifetuin is directed toward the protein H.  VAN  VUNAKIS,  A. RUFFILLI,  AND  L. LEVINE  275 
moiety d  this  glycoprotein,  this  increase  in  serological  activity with  siallc 
acid-free fetuin was thought to be due to the removal of the strong negatively 
charged portion of the fetuin molecule,  thus allowing better interaction of the 
protein moiety with the antibody. A similar  explanation for the increase  in  C' 
fixation  of fetuin  after incubation  with  hemoglobin  is possible.  Hemoglobin 
may complex with the sialic acid containing carbohydrate moiety of fetuin to 
neutralize its negative charge,  and thus make possible better interaction of the 
protein moiety of fetuin with its antibody. 
DISCUSSION 
Two experimental results have been described in this paper. Hemoglobin and 
its chains can enhance the antibiotic activity of coficine K  and are also able 
to interact with colicine K as well as other O antigens to alter their serological 
activities.  Most likely,  hemoglobin  and  its subunits  complex with  the lipo- 
polysaccharide  to  mask  some  of its  antigenic  determinants.  In  the  case  of 
colicine K, dissociation  of the antibiotic activity also occurs. Evidence to sup- 
port this conclusion  was obtained from experiments in which colicine K  that 
had been incubated with the alpha chains  of hemoglobin  was subjected to gel 
filtration  through  sephadex.  The elufion pattern  revealed that  the antibiotic 
activity was significantly  retarded but that there was no alteration in the loca- 
tion of the lipocarbohydrate moiety. The serological activity of the lipocarbo- 
hydrate  moiety with anticolicine  was altered,  however. The possibility that 
the lipocarbohydrate fragmented to release the antibiotic activity (assumed to 
be protein) and repolymerized rapidly to form a large molecular weight com- 
plex cannot be definitely ruled out. The fate of the alpha chain could not be 
determined in these experiments.  Antibodies specific for the alpha  chain  are 
currently being prepared for this purpose. 
Some role for electrostatic forces in the interaction between hemoglobin  and 
O  antigens  is suggested by its inhibition  at  high  concentrations  of salt and 
relatively low concentrations of divalent cations.  Alterations in the serological 
activity of coficine K  are also obtained with the basic proteins, Hbonuclease 
and lysozyme, and polylysine but higher concentrations of these cationic mole- 
cules were required (10). Ribonuclease and polylysine do not enhance colicine 
K  antibiotic activity and lysozyme is only one-twentieth as effective as hemo- 
globin.  Thus,  two reactions, one leading to complex formation with displace- 
ment of the antibiotic portion  (as is seen with hemoglobin,  its subunits and 
myoglobin) and the other leading to complex formation without displacement 
of the antibiotic moiety, may be occurring.  Evidence for complex formation has 
also been obtained using a turhidometric assay (24). 
While hemoglobin  and its chains  have been shown to interact with colicine 
K,  E.  coli,  Sh. flexneri,  S.  typhimurium,  S.  typhosa,  S.  enteriditis,  S.  abortus 
equi,  and S.  marcescens  lipopolysaccharides,  they do not interact  with other 
polysaccharide immune systems such as Pneumococcus Type II (composed of 276  ALTERATION OF COLICINE K 
rhamnose,  glucose, and glucuronic  acid), Pneumococcus  Type VIII (composed 
of galactose,  glucose,  and  glucuronic  acid),  Pneumococcus  Type XIV  (com- 
posed of glucose and galactose)  and T4 DNA (glucosyl 5-OH methylcytosine, 
adenine,  guanine,  thymine, deoxyribose,  and phosphate). A clue to the residue 
in the endotoxin mediating the interaction with hemoglobin  may be seen from 
the increased  C' fixation  of the fetnin immune system. Fetuin, preincubated 
with hemoglobin,  gives an immunological  response  similar  to fetuin in which 
the sialic acid was removed with neuraminidase  (23). It should be noted that 
the haptoglobins, which avidly complex with the hemoglobin  in the sera,  also 
contain sialic acid. 2-Keto-3-deoxyoctonate (KDO) has recently been identified 
in the lipopolysaccharides  of the Escherichia-Salraonella  group (25).  Whether 
the sialic acid in glycoproteins and KDO in O antigens are part of the hemo- 
globin binding sites remains to be answered, especially since colicine K has not 
been shown to contain KDO (3). 
The inhibition with excess hemoglobin  and its subunits resembles the inhibi- 
tion seen with excess antigen in antigen-antibody precipitin or C r fixation reac- 
tions.  It is possible that the alpha chain-lipopolysaccharide complex,  like the 
antigen-antibody reaction,  involves multivalencies on both the alpha chain (or 
beta  chain  or  hemoglobin)  and  the  lipopolysaccharide.  Preliminary  experi- 
ments designed  to identify the active amino sequence in hemoglobin and the 
chains  showed that partial  digestion by trypsin leads to a  loss of serological 
alteration  activity. The digested fragments,  however, still  can combine with 
portions  of the lipopolysaccharide as measured by competition experiments. 
Continued digestion,  however, results  in small  fragments unable to compete 
with hemoglobin  or alpha and beta chains  for the lipopolysaccharide binding 
sites. 
The evidence is accumulating  that  complex  formation between endotoxins 
and various proteins can alter the biological and serological properties of endo- 
toxins.  The  ability of strong  cationic  macromolecules  and  proteins  to  inac- 
tivate the tumor-necrotizing activity of S. marcescens  endotoxin could be re- 
versed by treating the complexes with the polyanion, polyglucose  sulfate (26, 
27). Using proteolytic enzyme digestion,  Rudbach and Johnson (28) have also 
been able to restore pyrogenic and immunological  activities to S. typhosa endo- 
toxin previously rendered inactive by treatment with Cohn fraction IV-1. Some 
humoral and tissue factors are thought to affect the biological and serological 
activities of endotoxins because they possess  enzymatic activities. The possi- 
bility that  complex formation may be responsible  for the observed effects  in 
some of these instances has been stressed (27, 28). 
There are several reasons for believing  that the hemoglobin  components are 
also probably the factors in serum and tissue which are capable of enhancing 
the activity of colicine K  and may be important factors in altering the sero- 
logical activity of O antigens.  Hemoglobin, globin, and its subunits do not exist 
free in serum or plasma since they form extremely strong complexes with the I~. VAN  VIYNAKIS,  A.  RUF]~ILLI,  AND  L. LEVINE  277 
haptoglobins, a  molecularly heterogeneous group of glycoproteins which are 
under genetic control (29).  While hemoglobin and globin have electrophoretic 
mobilifies of beta globulins, they migrate when complexed with haptoglobins, 
as alpha globulins (30).  In addition, chromatography of sera on DEAE cellu- 
lose showed that CEF activity emerged in the same area as the haptoglobin- 
hemoglobin complexes.  Since haptoglobins are  genetically different and com- 
plex with globin and its subunits as well as with hemoglobin, the multiple peaks 
of activity observed during the purification of CEF from fraction IV-1  pre- 
pared from pooled outdated plasma is an expected finding. The stability of CEF 
to heat, urea, and extremes in pH is also consistent with what has been ob- 
served  with  the  hemoglobin  components.  As  far as  the  distribution of  the 
factor in tissues goes, it was apparent that those tissues which contained the 
greatest amount of blood had the highest specific activity. The isolation pro- 
cedure that was being evolved was in fact similar to those used to produce and 
isolate hemoglobin chains (19). 
S~ARY 
Hemoglobin, its  chains,  and myoglobin enhance the antibiotic activity of 
colicine K. These proteins also interact with colicine  K  and other O antigens 
to alter their serological activity. The hemoglobin proteins did not alter the 
serological activities  of  three  Pneumococcus  polysaccharides or  T4  bacterio- 
phage DNA antigens but did alter the antigenic activity of fetuin. 
Interaction of hemoglobin and colicine K resulted in a retardation of colicine 
K  antibiotic moiety as measured by gel filtration but did not affect the gel fil- 
tration properties of the lipopolysaccharide moiety. 
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